A review of genericmedicine pricing in Europe

@inproceedings{Simoens2012ARO,
  title={A review of genericmedicine pricing in Europe},
  author={Professor Dr Steven Simoens},
  year={2012}
}
Intr oduction Generic medicines are a key instrument for governments to sustain their healthcare systems and control pharmaceutical expenditures. This contribution of generic medicines to the sustainability of European healthcare systems has been recognised by the High Level Pharmaceutical Forums, ‘Generic medicines provide an opportunity to obtain similar treatments at lower costs for patients and payers, while liberating budgets for financing new innovative medicines’ [1]. WHO also emphasises… CONTINUE READING
Highly Cited
This paper has 37 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Pricing strategies of originator and generic medicines following patent expiry in Belgium

  • M Adriaen, K De Witte, S. Simoens
  • Journal of Generic Medicines
  • 2008
Highly Influential
10 Excerpts

Sustaining generic medicines markets in Europe

  • S Simoens, S. De Coster
  • Journal of Generic Medicines
  • 2006
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…